Actos Bladder Cancer Lawsuits May Reach 10,000December 5, 2011 — Takeda Pharmaceutical Co., the largest pharmaceutical company in Asia, is under increasing pressure regarding its diabetes drug, Actos (generic: pioglitazone) which has been linked to an increased risk of life-threatening side effects, including bladder cancer, heart attacks, and stroke. According to a Bloomberg news report, Takeda may face up to 10,000… Read More









